Authors | Ruben A Mesa, Animesh D Pardanani, Kebede Hussein, Wenting Wu, Susan Schwager, Mark R Litzow, William J Hogan, Ayalew Tefferi |
Journal | American journal of hematology
(Am J Hematol)
Vol. 85
Issue 2
Pg. 129-30
(Feb 2010)
ISSN: 1096-8652 [Electronic] United States |
PMID | 20052748
(Publication Type: Clinical Trial, Phase I, Clinical Trial, Phase II, Letter)
|
Chemical References |
- Anti-Inflammatory Agents
- Immunosuppressive Agents
- Thalidomide
- Prednisolone
- pomalidomide
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Anemia
(drug therapy, etiology, pathology)
- Anti-Inflammatory Agents
(administration & dosage)
- Female
- Humans
- Immunosuppressive Agents
(administration & dosage)
- Male
- Maximum Tolerated Dose
- Middle Aged
- Prednisolone
(administration & dosage)
- Primary Myelofibrosis
(complications, drug therapy, pathology)
- Thalidomide
(administration & dosage, analogs & derivatives)
|